When did Corvus Pharmaceuticals report Q4 2024 earnings?

Corvus Pharmaceuticals (CRVS) reported Q4 2024 earnings on March 25, 2025 after market close.

What were Corvus Pharmaceuticals's Q4 2024 revenue and EPS?

Corvus Pharmaceuticals reported eps of $-0.18 for Q4 2024.

Did Corvus Pharmaceuticals beat estimates in Q4 2024?

EPS missed the consensus estimate of $-0.12 by $0.06.

Where can I find Corvus Pharmaceuticals's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001558370-25-003621) directly on SEC EDGAR. The filing index links above go to sec.gov.

Corvus Pharmaceuticals CRVS Q4 2024 Annual earnings

Reported March 25, 2025 · After market close

EPS-$0.18Miss by $0.06

EPS estimate-$0.12

Next report

Aug 6, 2026 (In 1 week)

EPS estimate-$0.17

Financials

Q4 2024

Income statement

See full

Operating income-$8.1M-43.4%

Net income-$12.1M-82.1%

EPS (diluted)-$0.16-23.1%

Balance sheet

See full

Cash & equivalents$8.7M-30.7%

Total debt$1.1M-18.3%

Total equity$32.6M-15.8%

Total assets$68.9M+51.3%

Cash flow

See full

Operating cash flow-$8.5M-63.8%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$343.78M+298%

Enterprise value$336.16M+348%

Returns & leverage

See full

Return on equity-174.9%-339pp

Debt / equity0×0.0×

Current ratio1.5×-2.5×

Versus estimates

Diluted EPS

Q1 2026-$0.15Miss by $0.01 Q4 2025-$0.15Miss by $0.01 Q3 2025-$0.12Beat by $0.02 Q2 2025-$0.10Beat by $0.03 Q1 2025-$0.13In line

Q4 2024-$0.18Miss by $0.06

Ask the moment Corvus Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Corvus Pharmaceuticals report Q4 2024 earnings?: Corvus Pharmaceuticals (CRVS) reported Q4 2024 earnings on March 25, 2025 after market close.
What were Corvus Pharmaceuticals's Q4 2024 revenue and EPS?: Corvus Pharmaceuticals reported eps of $-0.18 for Q4 2024.
Did Corvus Pharmaceuticals beat estimates in Q4 2024?: EPS missed the consensus estimate of $-0.12 by $0.06.
Where can I find Corvus Pharmaceuticals's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001558370-25-003621) directly on SEC EDGAR. The filing index links above go to sec.gov.